Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 657 | $430,299,687 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
02 Dec 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2022 | Sale | 3 | 752.57 | 2,258 | D |
12 Dec 2022 16:35 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 08 Dec 2022 | Sale | 218 | 779 | 169,822 | D |
13 Dec 2022 16:13 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 12 Dec 2022 | Sale | 264 | 730.17 | 192,765 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 311 | 716.08 | 222,701 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 2,266 | 715.48 | 1,621,278 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 1,022 | 714.61 | 730,331 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 1,198 | 713.66 | 854,965 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 100 | 711.95 | 71,195 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 679 | 710.63 | 482,518 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 1 | 709.92 | 710 | D |
30 Dec 2022 16:10 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 28 Dec 2022 | Sale | 181 | 707.87 | 128,124 | D |
05 Jan 2023 16:22 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 03 Jan 2023 | Sale | 1,100 | 721.86 | 794,046 | D |
05 Jan 2023 16:37 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jan 2023 | Sale | 2 | 732.18 | 1,464 | D |
05 Jan 2023 16:37 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jan 2023 | Sale | 12 | 731.59 | 8,779 | D |
05 Jan 2023 16:37 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jan 2023 | Sale | 4 | 730.35 | 2,921 | D |
05 Jan 2023 16:37 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jan 2023 | Sale | 1 | 729.92 | 730 | D |
05 Jan 2023 16:37 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jan 2023 | Sale | 11 | 728.34 | 8,012 | D |
05 Jan 2023 16:37 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jan 2023 | Sale | 13 | 727.59 | 9,459 | D |
05 Jan 2023 16:37 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jan 2023 | Sale | 10 | 726.34 | 7,263 | D |
05 Jan 2023 16:37 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jan 2023 | Sale | 9 | 725.63 | 6,531 | D |
05 Jan 2023 16:37 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jan 2023 | Sale | 9 | 724.52 | 6,521 | D |
05 Jan 2023 16:37 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jan 2023 | Sale | 10 | 723.52 | 7,235 | D |
05 Jan 2023 16:37 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jan 2023 | Sale | 5 | 722.59 | 3,613 | D |
05 Jan 2023 16:37 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Jan 2023 | Sale | 14 | 721.48 | 10,101 | D |
10 Jan 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 06 Jan 2023 | Sale | 3,070 | 747.14 | 2,293,720 | D |
30 Jan 2023 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 27 Jan 2023 | Sale | 1 | 747 | 747 | D |
03 Feb 2023 16:13 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Feb 2023 | Sale | 1,100 | 752.19 | 827,409 | D |
03 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2023 | Sale | 3 | 761.58 | 2,285 | D |
03 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2023 | Sale | 2 | 762.17 | 1,524 | D |
03 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2023 | Sale | 4 | 760.4 | 3,042 | D |
03 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2023 | Sale | 4 | 759.65 | 3,039 | D |
03 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2023 | Sale | 7 | 758.58 | 5,310 | D |
03 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2023 | Sale | 2 | 757.29 | 1,515 | D |
03 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2023 | Sale | 24 | 756.77 | 18,162 | D |
03 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2023 | Sale | 17 | 755.5 | 12,844 | D |
03 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2023 | Sale | 17 | 754.45 | 12,826 | D |
03 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2023 | Sale | 18 | 753.54 | 13,564 | D |
03 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Feb 2023 | Sale | 2 | 752.11 | 1,504 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 28 | 797.43 | 22,328 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 18 | 796.43 | 14,336 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 59 | 795.41 | 46,929 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 99 | 794.61 | 78,666 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 2 | 793.33 | 1,587 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 3 | 791 | 2,373 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 10 | 790.41 | 7,904 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 49 | 789.05 | 38,663 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 99 | 788.62 | 78,073 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 58 | 787.47 | 45,673 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 85 | 786.45 | 66,848 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 78 | 785.88 | 61,299 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 113 | 784.27 | 88,623 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 06 Feb 2023 | Sale | 51 | 783.05 | 39,936 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 03 Feb 2023 | Sale | 739 | 764.5 | 564,966 | D |
07 Feb 2023 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 03 Feb 2023 | Sale | 1,021 | 779 | 795,359 | D |
08 Feb 2023 16:14 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 07 Feb 2023 | Sale | 1,000 | 769.04 | 769,040 | D |
08 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 06 Feb 2023 | Sale | 13,189 | 800.08 | 10,552,255 | I |
08 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 06 Feb 2023 | Sale | 500 | 797 | 398,500 | I |
08 Feb 2023 16:15 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 06 Feb 2023 | Sale | 3,071 | 798 | 2,450,658 | D |
08 Feb 2023 16:16 | REGN | REGENERON PHARMACEUTICALS Inc | GOLDSTEIN JOSEPH L | Director | 06 Feb 2023 | Sale | 3,613 | 800 | 2,890,400 | D |
03 Mar 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Mar 2023 | Sale | 1,100 | 759.89 | 835,879 | D |
03 Mar 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2023 | Sale | 7 | 766.32 | 5,364 | D |
03 Mar 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2023 | Sale | 10 | 765.55 | 7,656 | D |
03 Mar 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2023 | Sale | 17 | 764.49 | 12,996 | D |
03 Mar 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2023 | Sale | 11 | 763.51 | 8,399 | D |
03 Mar 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2023 | Sale | 9 | 762.28 | 6,861 | D |
03 Mar 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2023 | Sale | 16 | 761.62 | 12,186 | D |
03 Mar 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2023 | Sale | 10 | 760.54 | 7,605 | D |
03 Mar 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2023 | Sale | 15 | 759.48 | 11,392 | D |
03 Mar 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Mar 2023 | Sale | 5 | 758.2 | 3,791 | D |
27 Mar 2023 16:37 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Controller | 23 Mar 2023 | Sale | 2,192 | 806.47 | 1,767,782 | D |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 400 | 810.3 | 324,120 | I |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 700 | 806.47 | 564,529 | I |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 47 | 805.55 | 37,861 | I |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 254 | 804.38 | 204,313 | I |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 642 | 803.3 | 515,719 | I |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 1,237 | 802.54 | 992,742 | I |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 122 | 801.16 | 97,742 | I |
27 Mar 2023 16:41 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | President and Chief Scientific | 23 Mar 2023 | Sale | 254 | 800.59 | 203,350 | I |
27 Mar 2023 16:43 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 24 Mar 2023 | Sale | 1,240 | 818 | 1,014,320 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 31 | 826.36 | 25,617 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 243 | 825.37 | 200,565 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 157 | 824.54 | 129,453 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 181 | 823.6 | 149,072 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 128 | 822.67 | 105,302 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 142 | 821.4 | 116,639 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 115 | 820.85 | 94,398 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 28 Mar 2023 | Sale | 10 | 818.81 | 8,188 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 7 | 830.01 | 5,810 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 4 | 829.16 | 3,317 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 13 | 825.59 | 10,733 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 4 | 824.3 | 3,297 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 18 | 822.57 | 14,806 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 48 | 821.39 | 39,427 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 50 | 820.46 | 41,023 | D |
29 Mar 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | LANDRY ROBERT E | EVP Finance CFO | 27 Mar 2023 | Sale | 39 | 819.47 | 31,959 | D |
05 Apr 2023 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 03 Apr 2023 | Sale | 1,100 | 818.8 | 900,680 | D |
05 Apr 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Apr 2023 | Sale | 6 | 823.34 | 4,940 | D |
05 Apr 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Apr 2023 | Sale | 9 | 822.37 | 7,401 | D |
05 Apr 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Apr 2023 | Sale | 1 | 821.61 | 822 | D |
05 Apr 2023 16:01 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 03 Apr 2023 | Sale | 5 | 820.55 | 4,103 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)